Related Experiment Video

Updated: Jul 17, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs

Luigi Quintieri1, Marianna Fantin, Csaba Vizler

  • 1Pharmacology Section, Department of Pharmacology and Anesthesiology, University of Padova, Largo Meneghetti, 2, Italy. luigi.quintieri@unipd.it

Advances in Experimental Medicine and Biology
|February 3, 2007
PubMed

Insights

Drug resistance is a major challenge in cancer chemotherapy. Gene expression analysis shows promise for predicting patient response to anticancer drugs, enabling personalized treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Drug resistance significantly impedes effective cancer chemotherapy.
  • Cellular mechanisms of resistance include altered drug transport, target modification, DNA repair, and apoptosis regulation.
  • Advances in gene expression profiling offer new avenues for understanding chemosensitivity.

Purpose of the Study:

  • To explore the relationship between gene expression patterns and anticancer drug sensitivity.
  • To identify potential multigenic markers for predicting clinical response to chemotherapy.

Main Methods:

  • Utilizing DNA microarrays to analyze the expression of thousands of genes simultaneously.
  • Investigating gene expression in tumor cell lines selected for drug resistance.
  • Conducting clinical studies correlating tumor gene expression with chemotherapy outcomes.

Main Results:

  • Studies using microarrays have identified genes associated with tumor chemosensitivity.
  • Clinical investigations suggest that gene expression patterns can predict chemotherapy response.
  • Encouraging results indicate the feasibility of personalized cancer treatment.

Conclusions:

  • Gene expression profiling is a valuable tool for understanding and overcoming drug resistance in cancer.
  • Multigenic response-predictive markers hold potential for tailoring chemotherapy to individual patients.
  • Personalized cancer therapy based on molecular profiling is a feasible future direction.

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...